Factor Xa

Download PDF

Recent Publications on Factor Xa:
Comparative effects of atrial polypeptide and neurohormone C on the interaction of factor Xa with antithrombin III. The effects of atrial polypeptide and neurohormone C upon the interaction...	4th October, 2008	aDepartment of Biological Sciences, USA bDepartment of Chemistry, Bowling	Blood Coagul Fibrinolysis. 2008 Oct;19(7):645-51. DOI Direct Link
APIXABAN METABOLISM AND PHARMACOKINETICS FOLLOWING ORAL ADMINISTRATION TO HUMANS. The metabolism and disposition of [(14)C]apixaban, an orally bioavailable,...	4th October, 2008	Bristol-Myers Squibb.	Drug Metab Dispos. 2008 Oct 2. DOI Direct Link
Prevention of venous thromboembolism in hospitalized medical patients. The hospitalized medical patient in the US today has multiple risk factors...	2nd October, 2008	Division of Hospital Medicine, University of Miami, Miller School of	Mt Sinai J Med. 2008 Sep 30;75(5):449-453. DOI Direct Link
Anti-factor Xa Plasma Levels in Pregnant Women Receiving Low Molecular Weight Heparin Thromboprophylaxis. OBJECTIVE: To report the incidence of prophylactic, subprophylactic, and...	2nd October, 2008	Maternal Fetal Medicine Associates, PLLC, and the Department of	Obstet Gynecol. 2008 Oct;112(4):884-889. DOI Direct Link
Differential Effects of Factor IIa Inhibitors on the Endogenous Thrombin Potential. ABSTRACT:: Calibrated automated thrombin generation measurement in...	1st October, 2008	From the *Institut fur Pharmakologie, Universitat Duisburg-Essen,	Ther Drug Monit. 2008 Sep 26. DOI Direct Link
→View more research publications.

BioNews Results for Factor Xa:
Bayer's Novel Oral Anticoagulant Xarelto (Rivaroxaban) Gets European Licence	Drugs.com:  Oct 3 2008 7:34AM Matching: factor xa
Bayer's Novel Oral Anticoagulant Xarelto (Rivaroxaban) Gets European Licence	Pharma Live:  Oct 3 2008 5:42AM Matching: factor xa
Apixaban Metabolism And Pharmacokinetics Following Oral Administration To Humans	Drug Metabolism And Disposition:  Oct 3 2008 1:53AM Matching: factor xa
Bayer wins European approval for Xarelto pill	Reuters Health:  Oct 2 2008 12:40AM Matching: factor xa
UPDATE 1-Bayer wins European approval for Xarelto pill	Forbes.com:  Oct 1 2008 4:59PM Matching: factor xa
Promote your company here: BioNewsCast - Press Release Distribution	→View more news.

Factor Xa Clinical Trials:
Factor Xa Inhibitor for Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement	Thromboembolism Interventions: Drug: YM150;   Drug: enoxaparin

Factor Xa Patents:
US Patent No.	Title
7422848	Hepatitis-B viral variants with reduced susceptibility to nucleoside analogs and uses thereof
7425531	Bone polypeptide-1
7425539	Factor IXa for the treatment of bleeding disorders
7425550	Lactam glycogen phosphorylase inhibitors and method of use
7425576	Compounds as inhibitors of hepatitis C virus NS3 serine protease
→View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Factor Xa scientists - we have details of around 485 individuals working on Factor Xa .

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.